ITK, IL2 inducible T cell kinase, 3702

N. diseases: 117; N. variants: 12
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE EnanDIM® molecules also drove regression of multiple other murine syngeneic tumors including MC38 colon carcinoma, B16 melanoma, A20 lymphoma, and EMT-6 breast cancer. 30621769 2019
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 AlteredExpression disease BEFREE In addition, taxifolin promoted the MET process, the reversed process of EMT, as evaluated by EMT markers and EMT-transcriptional factors in breast cancer cell lines. 31260685 2019
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE The conjugation of folic acid improved the uptake of nanoparticles in EMT-6 breast cancer overexpressing cell lines, and the uptake efficacy of DOX was remarkably increased by the laser irradiation. 30305210 2018
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE Here we report that a TRIM28-TWIST1-EMT axis exists in breast cancer cells and TRIM28 promotes breast cancer metastasis by stabilizing TWIST1 and subsequently enhancing EMT. 27412325 2016
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE Murine breast cancer EMT‑6 cells were manipulated to stably overexpress VEGF165 or VEGF183. 25373557 2015
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE The effect of clorgyline (CLG), a selective inhibitor of MAO-A, on malignant behaviour, expression of transitional markers, and biochemical correlates was examined in two human breast carcinoma cell lines, i.e. the epithelial, oestrogen receptor (ER)-positive MCF-7 cell line and the post-EMT (mesenchymal), ER-negative MDA-MB-231 cell line. 25152370 2014
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE Migration was assessed in luminal (MCF-7), post-EMT (MDA-MB-231, MDA-MB-435S), and basal-like (MDA-MB-468) human breast carcinoma cell lines under normal and oxygen-deprived conditions, using a collagen-based assay. 21535870 2011
CUI: C0678222
Disease: Breast Carcinoma
Breast Carcinoma
0.080 Biomarker disease BEFREE Specifically, basal-type and post-EMT breast cancer cell lines were most sensitive to growth inhibition by dasatinib. 17268817 2007